Earnings Per Share (Tables)

9 Months Ended

Mar. 30, 2024

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities and Outstanding Equity Awards

These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.

	Three Months Ended
	(in thousands, except share and per share information)
	March 30, 2024		April 1, 2023
Net income (loss)	$	(2,221)	$	1,976
Weighted average shares outstanding—basic	10,762		10,762
Effect of dilutive common stock awards	—		103
Weighted average shares outstanding—diluted	10,762		10,865
Net income (loss) per share—basic	$	(0.21)	$	0.18
Net income (loss) per share—diluted	$	(0.21)	$	0.18
Antidilutive SARs not included in diluted earnings per share	525		376

	Nine Months Ended
	(in thousands, except per share information)
	March 30, 2024		April 1, 2023
Net income	$	(802)	$	4,094
Weighted average shares outstanding—basic	10,762		10,762
Effect of dilutive common stock awards	—		130
Weighted average shares outstanding—diluted	10,762		10,892
Net income per share—basic	$	(0.07)	$	0.38
Net income per share—diluted	$	(0.07)	$	0.38
Antidilutive SARs not included in diluted earnings per share	652		516